Published in TB and Outbreaks Week, October 25th, 1999
But that may be changing.
Researchers have begun to wonder aloud whether directly observed therapy (DOT), and especially universal DOT, is the best use of limited tuberculosis funding.
In a recent editorial, L. Peter Ormerod of the United Kingdom's University of Central Lancashire asked whether the data supporting the superior efficacy of DOT are being misinterpreted. He noted that DOT programs tend to have greater economic resources that may positively influence factors independent of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week